INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 46h ago
House PTR6h ago
SEC 13F6h ago
Robinhood Chain6h ago

Most active filers · 30d

  1. 01FWFogarty Patrick W0B / 206S206 trades$1.10M
  2. 02Kurtz George0B / 202S202 trades$48.06M
  3. 03SPSaba Capital Management, L.P.67B / 19S · 11 late86 trades$21.51M
  4. 04NYNissan Yitzhak82B / 0S · 79 late82 trades$2.61M
  5. 05ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  6. 06AJAllaire Jeremy0B / 50S50 trades$4.26M
  7. 07Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  8. 08SJSheena Jonathan0B / 45S45 trades$3.01M
  9. 09SISarowitz Steven I2B / 34S36 trades$21.18M
  10. 10SLSpeiser Michael L0B / 35S35 trades$14.00M

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 1732 insiders$917K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 179 insiders$893K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 168 insiders$42.58M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLMGNIMAGNITE, INC.Nov 5 – Nov 178 insiders$2.77M
  7. SELLIBEXIBEX LtdNov 9 – Nov 167 insiders$3.36M
  8. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M

Form 4 transactions

73,367 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
32
WA
Wilson Kelli AnnEVP Chief Banking Officer
HFWAHERITAGE FINANCIAL CORP /WA/
Open-market sale
SELL$50K
1,900 sh
Jan 26, 2026
Page 1445 of 1835
← PrevNext →
Jan 26, 2026
traded Jan 26, 2026
+0d
SEC Form 4

Evidence

32
BH
Bhatia Manish HEVP, Global Operations
MUMICRON TECHNOLOGY INC
Open-market sale
SELL$911K
2,300 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

32
SC
Schwab-Pomerantz CarolynDirector
SCHWSCHWAB CHARLES CORP
Open-market sale
SELL$500K
4,765 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

30
IJ
Idell JenniferChief Administrative Officer
SSBSouthState Bank Corp
Grant or award
A$144K
1,485 sh
Jan 20, 2026Jan 26, 2026
traded Jan 20, 2026
+6dSEC Form 4

Evidence

30
TR
Taub RebeccaDirector
MDGLMADRIGAL PHARMACEUTICALS, INC.
Open-market sale
SELL$319K
647 sh
Jan 26, 2026Jan 26, 2026
traded Jan 26, 2026
+0dSEC Form 4

Evidence

29
BH
Beckwith Van H.EVP, Secretary and CLO
HALHALLIBURTON CO
Open-market sale · 10b5-1 plan
SELL$1.90M
54.3K sh
Jan 23, 2026Jan 26, 2026
traded Jan 23, 2026
+3dSEC Form 4

Evidence

27
OP
O'Day Daniel PatrickDirector, Chairman & CEO
GILDGILEAD SCIENCES, INC.
Open-market sale · 10b5-1 plan
SELL$15.61M
115.6K sh
Jan 23, 2026Jan 26, 2026
traded Jan 23, 2026
+3dSEC Form 4

Evidence

27
AS
Arana SaraChief Accounting Officer
SSBSouthState Bank Corp
Grant or award
A$27K
282 sh
Jan 20, 2026Jan 26, 2026
traded Jan 20, 2026
+6dSEC Form 4

Evidence

26
GM
Gass MichelleDirector, President & CEO
LEVILEVI STRAUSS & CO
Tax withholding
F$2.58M
119.9K sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

26
IJ
Idell JenniferChief Administrative Officer
SSBSouthState Bank Corp
Grant or award
A$216K
2,227 sh
Jan 20, 2026Jan 26, 2026
traded Jan 20, 2026
+6dSEC Form 4

Evidence

26
SJ
Singh Harmit JEVP & Chief Fin. & Growth Ofc.
LLEVILEVI STRAUSS & CO
Tax withholding
F$2.33M
107.9K sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

25
HC
Huntsman CaroleChief Commercial Officer
MDGLMADRIGAL PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$282K
570 sh
Jan 26, 2026Jan 26, 2026
traded Jan 26, 2026
+0dSEC Form 4

Evidence

24
CD
Crane Benton DelossDirector
ANGXAngel Studios, Inc.
Derivative conversion
C—
200.0K sh
Nov 26, 2025Jan 26, 2026
traded Nov 26, 2025
+61dSEC Form 4

Evidence

24
HD
Hahnfeld Jeffrey DEVP-CONTROLLER & CHIEF ACC OFF
WTFCWINTRUST FINANCIAL CORP
Grant or award
A$166K
1,088 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

23
AS
Arana SaraChief Accounting Officer
SSBSouthState Bank Corp
Grant or award
A$41K
423 sh
Jan 20, 2026Jan 26, 2026
traded Jan 20, 2026
+6dSEC Form 4

Evidence

23
SM
Spurgin Jim MarkSVP Chief Supply Chain Officer
CBRLCRACKER BARREL OLD COUNTRY STORE, INC
Tax withholding
F$10K
318 sh
Jan 17, 2026Jan 26, 2026
traded Jan 17, 2026
+9dSEC Form 4

Evidence

23
UJ
Unruch JoelGeneral Counsel/Corp Secretary
ACNAccenture plc
Open-market sale · 10b5-1 plan
SELL$60K
214 sh
Jan 23, 2026Jan 26, 2026
traded Jan 23, 2026
+3dSEC Form 4

Evidence

23
UJ
Unruch JoelGeneral Counsel/Corp Secretary
ACNAccenture plc
Open-market sale · 10b5-1 plan
SELL$172K
610 sh
Jan 23, 2026Jan 26, 2026
traded Jan 23, 2026
+3dSEC Form 4

Evidence

22
BA
Bachrodt AmySVP, Finance
MAZEMaze Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$228K
5,000 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

21
BK
Budur KumarCHIEF MEDICAL OFFICER
HRMYHarmony Biosciences Holdings, Inc.
Option exercise
M—
2,188 sh
Jan 24, 2026Jan 26, 2026
traded Jan 24, 2026
+2dSEC Form 4

Evidence

21
SA
Serafin AndrewCHIEF STRATEGY OFFICER
HRMYHarmony Biosciences Holdings, Inc.
Option exercise
M—
2,600 sh
Jan 25, 2026Jan 26, 2026
traded Jan 25, 2026
+1dSEC Form 4

Evidence

21
SA
Serafin AndrewCHIEF STRATEGY OFFICER
HRMYHarmony Biosciences Holdings, Inc.
Tax withholding
F$41K
1,126 sh
Jan 25, 2026Jan 26, 2026
traded Jan 25, 2026
+1dSEC Form 4

Evidence

21
KB
Kinney Shannon BrowningEVP, CAO, GC & Corp Secretary
CHRDChord Energy Corp
Grant or award
A—
2,700 sh
Jan 23, 2026Jan 26, 2026
traded Jan 23, 2026
+3dSEC Form 4

Evidence

21
RR
Roslansky RyanDirector
INTUINTUIT INC.
Option exercise
M—
418 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

21
UM
Urist MarshallEVP, Research & Investments
RPRXRoyalty Pharma plc
Open-market sale · 10b5-1 plan
SELL$805K
20.0K sh
Jan 23, 2026Jan 26, 2026
traded Jan 23, 2026
+3dSEC Form 4

Evidence

21
MT
Mawakana TekedraDirector
INTUINTUIT INC.
Option exercise
M—
694 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

21
HJ
Henke Darrin J.EVP and COO
CHRDChord Energy Corp
Grant or award
A—
11.1K sh
Jan 23, 2026Jan 26, 2026
traded Jan 23, 2026
+3dSEC Form 4

Evidence

21
MI
Mat IshbiaDirector, President and CEO, 10% Owner
UWMCUWM Holdings Corp
Open-market sale · 10b5-1 plan
SELL$3.64M
632.9K sh
Jan 26, 2026Jan 26, 2026
traded Jan 26, 2026
+0dSEC Form 4

Evidence

21
GC
Gowasack Andrew CarlDirector, President
IDAIT Stamp Inc
Grant or award
A—
68.4K sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

21
KB
Kinney Shannon BrowningEVP, CAO, GC & Corp Secretary
CHRDChord Energy Corp
Grant or award
A—
8,642 sh
Jan 23, 2026Jan 26, 2026
traded Jan 23, 2026
+3dSEC Form 4

Evidence

21
SA
Serafin AndrewCHIEF STRATEGY OFFICER
HRMYHarmony Biosciences Holdings, Inc.
Tax withholding
F$41K
1,116 sh
Jan 24, 2026Jan 26, 2026
traded Jan 24, 2026
+2dSEC Form 4

Evidence

21
HJ
Henke Darrin J.EVP and COO
CHRDChord Energy Corp
Grant or award
A—
3,461 sh
Jan 23, 2026Jan 26, 2026
traded Jan 23, 2026
+3dSEC Form 4

Evidence

21
RR
Roslansky RyanDirector
INTUINTUIT INC.
Option exercise
M—
469 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

21
KJ
Kroll Lara JSVP & Chief Accounting Officer
CHRDChord Energy Corp
Grant or award
A—
634 sh
Jan 23, 2026Jan 26, 2026
traded Jan 23, 2026
+3dSEC Form 4

Evidence

21
SA
Serafin AndrewCHIEF STRATEGY OFFICER
HRMYHarmony Biosciences Holdings, Inc.
Option exercise
M—
2,500 sh
Jan 24, 2026Jan 26, 2026
traded Jan 24, 2026
+2dSEC Form 4

Evidence

21
SJ
Singh Harmit JEVP & Chief Fin. & Growth Ofc.
LLEVILEVI STRAUSS & CO
Grant or award
A—
213.7K sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

21
BE
Brown Daniel EDirector, President and CEO
CHRDChord Energy Corp
Grant or award
A—
10.5K sh
Jan 23, 2026Jan 26, 2026
traded Jan 23, 2026
+3dSEC Form 4

Evidence

21
RN
Robuck Richard NEVP, CFO and Treasurer
CHRDChord Energy Corp
Grant or award
A—
3,461 sh
Jan 23, 2026Jan 26, 2026
traded Jan 23, 2026
+3dSEC Form 4

Evidence

21
KS
Kapadia SandipCHIEF FINANCIAL OFFICER
HRMYHarmony Biosciences Holdings, Inc.
Option exercise
M—
4,725 sh
Jan 25, 2026Jan 26, 2026
traded Jan 25, 2026
+1dSEC Form 4

Evidence

21
KS
Kapadia SandipCHIEF FINANCIAL OFFICER
HRMYHarmony Biosciences Holdings, Inc.
Option exercise
M—
3,813 sh
Jan 24, 2026Jan 26, 2026
traded Jan 24, 2026
+2dSEC Form 4

Evidence